Zoladex
Drug timelines are a Plus or Pro feature.
60 regulatory and trial events tracked for Zoladex, covering 2007-04-23 to 2026-03-11. Get the full timeline:
Most recent: Clinical Trial Update: A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With HR+, HER2- Advanced Breast Cancer [Phase 1]